GO:2000049 positive regulation of cell-cell adhesion mediated by cadherin: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000049 describes any process that activates or increases the frequency, rate or extent of cadherin-mediated cell-cell adhesion, a core mechanism of tissue architecture and contact inhibition.
• Rap1 GTPase is a direct positive regulator of E-cadherin-mediated adhesion, increasing cadherin accumulation at cell contacts.
• Abl tyrosine kinases modulate cadherin-dependent adhesion both upstream and downstream of Rho family GTPases, illustrating layered positive control.
• IQGAP1 acts as a key scaffold that integrates actin and microtubule dynamics with cadherin adhesion complexes.
• Loss of positive regulation of cadherin adhesion is linked to tumor progression, including prostate, thyroid and ovarian cancers [2,4,6].
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators of GO:2000049 [1,2,5,7].
Description
GO:2000049, positive regulation of cell-cell adhesion mediated by cadherin, is a biological process term that captures any molecular event that activates or increases the frequency, rate or extent of cadherin-dependent cell-cell adhesion. Cadherins are transmembrane adhesion receptors whose extracellular domains engage in homophilic binding, while their cytoplasmic tails couple to the actin cytoskeleton through catenins. Because cadherin adhesion is not a static structural feature but a dynamically regulated process, positive regulators such as Rap1, Abl kinases and IQGAP1 are essential for tissue integrity and contact inhibition [1,7,8]. For researchers, GO:2000049 provides a precise annotation target when studying how cells strengthen junctions, resist dissociation or suppress invasive behavior [1,5]. Experimental evidence shows that E-cadherin engagement can inhibit tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression, directly linking positive cadherin regulation to growth control. Conversely, reduced cadherin-mediated adhesion is observed in anaplastic thyroid carcinoma and prostatic adenocarcinoma, where catenin and cadherin proteins are co-downregulated [4,6]. Understanding GO:2000049 therefore requires integrating GTPase signaling, kinase regulation, scaffold proteins and cytoskeletal coupling [1,7,8]. This article summarizes the ontology definition, core mechanisms, key genes, disease relevance and CRISPR-based methods used to study positive regulation of cadherin-mediated cell-cell adhesion [1,2,5,7].
positive regulation of cell-cell adhesion mediated by cadherin At A Glance
| GO ID | GO:2000049 |
|---|---|
| GO term | positive regulation of cell-cell adhesion mediated by cadherin |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the frequency, rate or extent of cadherin-mediated cell-cell adhesion |
| Regulatory input | Rap1 GTPase, Abl tyrosine kinases, Rho family GTPases and IQGAP1 [1,7,8] |
| Cellular context | Adherens junctions, actin cytoskeleton and catenin complexes |
| Disease relevance | Prostate, thyroid and ovarian cancers; tumor growth suppression [2,4,5,6] |
What Is GO:2000049?
GO:2000049 is defined as any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin. In practice, this includes signaling events that recruit cadherins to junctions, stabilize cadherin-catenin complexes, promote actin coupling, or enhance the strength and duration of cadherin-dependent contacts [1,7,8]. It is a positive regulatory term, so annotations require evidence that a perturbation increases cadherin-mediated adhesion rather than merely being associated with it [1,7].
Why Is positive regulation of cell-cell adhesion mediated by cadherin Important in Cell Biology?
Positive regulation of cadherin-mediated cell-cell adhesion is central to tissue morphogenesis, barrier function and contact inhibition, and its dysregulation is a recurring theme in cancer progression [1,5]. Because cadherin adhesion can suppress proliferative signaling through PTEN induction, positive regulators of this process act as brakes on tumor cell growth. At the same time, cadherin and catenin downregulation is observed in aggressive carcinomas, making GO:2000049 a valuable framework for interpreting adhesion phenotypes [4,6].
• Maintains tissue architecture by strengthening cadherin-dependent junctions.
• Supports contact inhibition of proliferation via E-cadherin-mediated PTEN induction.
• Integrates GTPase signaling with adhesion through Rap1 and Rho family GTPases [1,7].
• Requires scaffold proteins such as IQGAP1 to couple adhesion to the cytoskeleton.
• Its loss is associated with anaplastic thyroid carcinoma and aberrant catenin expression.
• Co-downregulation of E-cadherin, catenins and p120CTN occurs in prostatic adenocarcinoma.
• MLK3 regulates E-cadherin in ovarian cancer spheroids, linking kinase signaling to adhesion.
• Bcl-2 expression can decrease cadherin-mediated cell-cell adhesion, showing negative crosstalk.
• Provides a mechanistic target for CRISPR-based perturbation studies [1,2,5,7].
What Happens During positive regulation of cell-cell adhesion mediated by cadherin?
Initiation by Rap1 GTPase signaling
In simple terms: Rap1 acts like a switch that tells cells to stick together more tightly.
Rap1 GTPase positively regulates E-cadherin-mediated cell-cell adhesion, increasing cadherin accumulation at cell contacts. This establishes a signaling entry point for GO:2000049, where activation of a small GTPase translates into stronger cadherin-dependent junctional adhesion.
Kinase modulation by Abl and MLK3
In simple terms: Certain kinases tune the adhesion machinery up or down.
Abl tyrosine kinases modulate cadherin-dependent adhesion both upstream and downstream of Rho family GTPases, placing kinase activity within the positive regulatory network. In ovarian cancer spheroids, mixed lineage kinase 3 (MLK3) regulates E-cadherin and thereby mediates cell adhesion, showing that kinase pathways can directly influence cadherin function.
Scaffolding and cytoskeletal coupling by IQGAP1
In simple terms: IQGAP1 is a connector that links adhesion receptors to the cell skeleton.
IQGAP1 is a key regulator of adhesion and migration that integrates actin and microtubule dynamics with cadherin adhesion complexes. This scaffold function supports the positive regulation of cadherin-mediated adhesion by stabilizing the link between cadherin-catenin complexes and the cytoskeleton.
Catenin complex stabilization and PTEN-linked growth suppression
In simple terms: When cadherins engage, they can send a signal that slows cell growth.
E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression. This links positive regulation of cadherin adhesion to downstream transcriptional and signaling outputs, including growth suppression.
Negative crosstalk and disease-associated loss
In simple terms: Some signals weaken adhesion, and this happens in several cancers.
Bcl-2 expression decreases cadherin-mediated cell-cell adhesion, demonstrating that positive regulation can be opposed by anti-adhesive signals. In anaplastic thyroid carcinoma, N-cadherin-mediated adhesion is accompanied by aberrant catenin expression, and prostatic adenocarcinomas show co-downregulation of alpha- and beta-catenins, p120CTN, E-cadherin and CD44.
Key Genes Involved in GO:2000049 positive regulation of cell-cell adhesion mediated by cadherin
The following genes and proteins are experimentally implicated in the positive regulation of cadherin-mediated cell-cell adhesion or in its dysregulation in disease [1,2,3,4,5,6,7,8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAP1 | Positively regulates E-cadherin-mediated cell-cell adhesion | GTPase switch controlling cadherin accumulation at contacts |
| ABL1 | Modulates cadherin-dependent adhesion upstream and downstream of Rho GTPases | Tyrosine kinase node in adhesion regulation |
| IQGAP1 | Scaffold linking adhesion complexes to actin and microtubules | Key regulator of adhesion and migration |
| CDH1 | E-cadherin; mediates homophilic adhesion and suppresses PI3K/Akt via PTEN | Central adhesion receptor and tumor suppressor axis |
| CTNNB1 | Beta-catenin; couples cadherin to actin and to Egr1-mediated PTEN expression | Links adhesion to transcriptional growth control |
| CTNNA1 | Alpha-catenin; core adherens junction component | Co-downregulated in prostatic adenocarcinoma |
| CTNND1 | p120CTN; catenin family regulator of cadherin stability | Co-downregulated in prostatic adenocarcinoma |
| CD44 | Cell adhesion protein co-downregulated with cadherins in prostate cancer | Marker of adhesion network disruption |
| CDH2 | N-cadherin; mediates adhesion in anaplastic thyroid carcinoma | Context-dependent cadherin in tumor adhesion |
| MLK3 | Regulates E-cadherin and mediates adhesion in ovarian cancer spheroids | Kinase regulator of cadherin function |
| BCL2 | Expression decreases cadherin-mediated cell-cell adhesion | Anti-adhesive crosstalk node |
| RHO GTPases | Act downstream of Abl kinases in cadherin adhesion | Cytoskeletal regulators of junction strength |
| PIK3CA/AKT axis | Suppressed by E-cadherin via PTEN | Growth signaling output of cadherin engagement |
| EGR1 | Mediates beta-catenin-dependent PTEN expression | Transcriptional effector downstream of cadherin |
| PTEN | Induced by E-cadherin engagement; suppresses PI3K/Akt | Tumor suppressor linking adhesion to growth control |
How Is positive regulation of cell-cell adhesion mediated by cadherin Regulated?
Positive regulation of cadherin-mediated cell-cell adhesion is controlled by layered signaling inputs. Rap1 GTPase increases E-cadherin-mediated adhesion, while Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases. IQGAP1 scaffolds adhesion complexes to the cytoskeleton, and MLK3 regulates E-cadherin in ovarian cancer spheroids. Negative crosstalk exists: Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. Downstream, E-cadherin engagement suppresses PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression, providing a feedback link between adhesion and growth signaling.
positive regulation of cell-cell adhesion mediated by cadherin and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDH1 | Prostate adenocarcinoma; adhesion protein co-downregulation | CRISPR knockout in prostate cancer cell lines |
| CTNNB1 | Prostate adenocarcinoma; catenin downregulation | Point-mutation knock-in of catenin phospho-sites |
| CDH2 | Anaplastic thyroid carcinoma; aberrant catenin expression | Knockout in thyroid carcinoma cell lines |
| MLK3 | Ovarian cancer spheroids; E-cadherin regulation | Overexpression and knockout in spheroid models |
| BCL2 | Decreased cadherin-mediated adhesion | Overexpression in adhesion-competent cell lines |
Prostate cancer and adhesion protein downregulation
Prostatic adenocarcinomas show co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin and CD44, indicating that loss of positive cadherin regulation accompanies tumor progression.
Thyroid carcinoma and aberrant catenin expression
Anaplastic thyroid-carcinoma cell lines display N-cadherin-mediated adhesion and aberrant catenin expression, linking altered cadherin regulation to this aggressive cancer type.
Ovarian cancer spheroids and MLK3
Regulation of E-cadherin by mixed lineage kinase 3 (MLK3) mediates cell adhesion in ovarian cancer spheroids, identifying a kinase-dependent mechanism relevant to ovarian tumor biology.
Growth suppression and PTEN signaling
E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression, showing that positive cadherin regulation can directly oppose proliferative signaling.
From positive regulation of cell-cell adhesion mediated by cadherin-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Rap1 loss reduce cadherin adhesion? | RAP1 knockout cells |
| Do Abl kinase mutations alter junction strength? | ABL1 point-mutation knock-in |
| Can IQGAP1 tagging reveal adhesion complex dynamics? | Tagged knock-in of IQGAP1 |
| Does MLK3 overexpression strengthen spheroid adhesion? | MLK3 overexpression in ovarian cancer spheroids |
| Does Bcl-2 expression weaken cadherin adhesion? | BCL2 overexpression |
| Does E-cadherin engagement suppress PI3K/Akt? | CDH1 knockout and re-expression |
How to Study the positive regulation of cell-cell adhesion mediated by cadherin Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cell aggregation assay | Cadherin-dependent intercellular adhesion strength | Testing Rap1 or MLK3 perturbation [1,2] |
| Immunofluorescence junction imaging | Cadherin and catenin localization at contacts [1,8] | Visualizing adherens junction assembly [1,8] |
| Co-immunoprecipitation | Cadherin-catenin-scaffold interactions | Mapping IQGAP1-containing complexes |
| Western blot for phospho-Akt and PTEN | PI3K/Akt pathway suppression by E-cadherin | Testing growth signaling downstream of adhesion |
| qPCR/RNA-seq of adhesion genes | Expression of cadherins, catenins and CD44 | Profiling adhesion loss in prostate cancer models |
| Spheroid formation assay | Three-dimensional cell-cell adhesion | Ovarian cancer spheroid studies |
| Apoptosis/adhesion crosstalk assay | Effect of Bcl-2 on cadherin adhesion | Testing anti-adhesive signaling |
Adhesion assays and junction imaging
Cadherin-mediated cell-cell adhesion can be measured by cell aggregation assays and junctional imaging, as used to show Rap1 regulation of E-cadherin adhesion and MLK3-dependent adhesion in ovarian cancer spheroids.
Protein interaction and scaffold analysis
Because IQGAP1 scaffolds adhesion complexes to the cytoskeleton, co-immunoprecipitation and proximity-based proteomics are suitable for mapping cadherin-catenin-scaffold interactions.
Signaling pathway readouts
E-cadherin engagement suppresses PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression, so phospho-Akt, PTEN and Egr1 readouts are informative for positive regulation of cadherin adhesion.
Expression profiling in disease models
Co-downregulation of alpha- and beta-catenins, p120CTN, E-cadherin and CD44 in prostatic adenocarcinomas supports expression profiling of adhesion genes in tumor models.
How CRISPR Can Be Used to Study GO:2000049 positive regulation of cell-cell adhesion mediated by cadherin
Knockout
CRISPR knockout of RAP1, ABL1, IQGAP1, CDH1 or MLK3 enables loss-of-function tests of whether these genes are required for positive regulation of cadherin-mediated adhesion [1,2,5,7,8].
Point Mutation
Point-mutation knock-in can be used to dissect phospho-site or GTPase-cycle residues in ABL1, RAP1 or catenins, testing their contribution to cadherin-dependent adhesion [1,7].
Knock-in
Tagged knock-in of IQGAP1 or E-cadherin allows live-cell tracking of adhesion complex assembly and scaffold dynamics at junctions.
Overexpression
Overexpression of MLK3 or BCL2 can test gain-of-function effects on cadherin-mediated adhesion, including strengthening in spheroids or weakening at junctions [2,3].
How EDITGENE Supports positive regulation of cell-cell adhesion mediated by cadherin Research
Researchers studying positive regulation of cell-cell adhesion mediated by cadherin-related genes often need to determine whether a candidate gene is causally involved in strengthening cadherin-dependent junctions, and CRISPR-based perturbation is the most direct way to establish that causality [1,2,5,7].
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cell-cell adhesion mediated by cadherin research.
Frequently Asked Questions About positive regulation of cell-cell adhesion mediated by cadherin
What is GO:2000049?
GO:2000049 is the Gene Ontology term for any process that activates or increases the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
What genes are involved in positive regulation of cell-cell adhesion mediated by cadherin?
Key genes include RAP1, ABL1, IQGAP1, CDH1, CTNNB1, CTNNA1, CTNND1, CDH2, MLK3 and BCL2 [1,2,3,4,5,6,7,8].
How does Rap1 regulate E-cadherin-mediated cell-cell adhesion?
Rap1 GTPase positively regulates E-cadherin-mediated cell-cell adhesion by increasing cadherin accumulation at cell contacts.
What role do Abl tyrosine kinases play in cadherin adhesion?
Abl tyrosine kinases modulate cadherin-dependent adhesion both upstream and downstream of Rho family GTPases.
How is IQGAP1 involved in cadherin-mediated adhesion?
IQGAP1 is a key regulator of adhesion and migration that scaffolds adhesion complexes to actin and microtubule networks.
Can E-cadherin suppress tumor cell growth?
Yes, E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via beta-catenin-Egr1-mediated PTEN expression.
What happens to adhesion proteins in prostate cancer?
Prostatic adenocarcinomas show co-downregulation of alpha- and beta-catenins, p120CTN, E-cadherin and CD44.
Does Bcl-2 affect cadherin-mediated adhesion?
Bcl-2 expression decreases cadherin-mediated cell-cell adhesion.
What is the role of MLK3 in ovarian cancer spheroids?
Regulation of E-cadherin by mixed lineage kinase 3 (MLK3) mediates cell adhesion in ovarian cancer spheroids.
How can CRISPR be used to study GO:2000049?
CRISPR knockout, point-mutation, knock-in and overexpression models can test whether candidate genes causally regulate cadherin-mediated adhesion [1,2,5,7].
Conclusion
GO:2000049, positive regulation of cell-cell adhesion mediated by cadherin, is a mechanistically rich biological process driven by Rap1 GTPase, Abl kinases, IQGAP1 and kinase pathways such as MLK3 [1,2,7,8]. Its output is not only structural adhesion but also growth suppression through E-cadherin-mediated PTEN induction. Loss or weakening of this regulation is observed in prostate, thyroid and ovarian cancer models, making it a compelling target for CRISPR-based causal studies [2,4,6]. By combining knockout, point-mutation, knock-in and overexpression strategies with adhesion assays and signaling readouts, researchers can define which genes are required or sufficient for positive regulation of cadherin-mediated adhesion [1,2,3,5,7].
References
- 1. Price LS et al.. 2004. Rap1 regulates E-cadherin-mediated cell-cell adhesion.. J Biol Chem 279(34):35127-32 PMID: 15166221
- 2. Rozier MCJ et al.. 2026. Regulation of E-cadherin by mixed lineage kinase 3 (MLK3) mediates cell adhesion in ovarian cancer spheroids.. Biochim Biophys Acta Mol Cell Res 1873(3):120106 PMID: 41513046
- 3. Li L et al.. 2003. Bcl-2 expression decreases cadherin-mediated cell-cell adhesion.. J Cell Sci 116(Pt 18):3687-700 PMID: 12890751
- 4. Husmark J et al.. 1999. N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines.. Int J Cancer 83(5):692-9 PMID: 10521809
- 5. Lau MT et al.. 2011. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.. Oncogene 30(24):2753-66 PMID: 21297666
- 6. Kallakury BV et al.. 2001. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.. Hum Pathol 32(8):849-55 PMID: 11521230
- 7. Zandy NL et al.. 2008. Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases.. Cell Cycle 7(4):444-8 PMID: 18235247
- 8. Noritake J et al.. 2005. IQGAP1: a key regulator of adhesion and migration.. J Cell Sci 118(Pt 10):2085-92 PMID: 15890984
